Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.

Yuka AsamiMayumi Kobayashi KatoKengo HiranumaMaiko MatsudaYoko ShimadaMitsuya IshikawaTakafumi KoyamaMasaaki KomatsuRyuji HamamotoMinoru NagashimaYasuhisa TeraoAtsuo ItakuraTakashi KohnoAkihiko SekizawaKoji MatsumotoTomoyasu KatoKouya ShiraishiHiroshi Yoshida

Published in: British journal of cancer (2023)

A molecular classifier is a useful tool for determining prognosis and eligibility for molecularly targeted therapy in patients with endometrial cancer.

Keyphrases

endometrial cancer
single molecule
genome wide
gene expression